AGEN
Agenus Inc
NASDAQ: AGEN · HEALTHCARE · BIOTECHNOLOGY
$7.13
+7.22% today
Updated 2026-10-28
Market cap
$272.78M
P/E ratio
2.56
P/S ratio
2.06x
EPS (TTM)
$2.36
Dividend yield
—
52W range
$3 – $10
Volume
1.0M
Agenus Inc (AGEN) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$7.13
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.3B | $0.1B | $0.2B | $0.1B | $0.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 2.56x (capped 25x) · Margin: 69.30%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.